Aluminum Sulfate

• Uses Temporarily relieves minor skin irritations due to: Poison ivy Poison oak Poison sumac Insect bites Athlete's foot Rashes caused by soaps, detergents, cosmetics, or jewelryICD-10: B35.3

Directions Dissolve 1 to 3 packets in a pint (16 oz) of cool or warm water. Stir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3packets) aluminum acetate and is ready for use. For use as a soak: Soak affected area for 15 to 30 minutes as needed, or as directed by a doctor. Repeat 3 times a day or as directed by a doctor. Discard solution after each use. For use as a compress or wet dressing: Soak a clean, soft cloth in the solution. Apply cloth loosely to affected area for 15 to 30 minutes. Repeat as needed or as directed by a doctor. Discard solution after each use.

FOR EXTERNAL USE ONLY

1. 1Asthenia57.6%
2. 2Fall57.6%
3. 3Renal Failure57.6%
4. 4Anaemia46.1%
5. 5Constipation46.1%
6. 6Cough46.1%
7. 7Dizziness46.1%
8. 8Dry Skin46.1%
9. 9Fatigue46.1%
10. 10Oropharyngeal Pain46.1%
11. 11Pain46.1%
12. 12Rash46.1%
13. 13Sinusitis46.1%
14. 14Abdominal Distension34.5%
15. 15Atrial Fibrillation34.5%

Recent PubMed references pinned to Aluminum Sulfate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Molecular-level interaction mechanisms of humic acid and residual aluminum species in gypsum scaling during nanofiltration.
  Water research · 2026 · Jia J, Zhang X, Lin D, et al.
  PMID 42208184DOI 10.1016/j.watres.2026.126126
• Evaluate of the protective effect of an RSV Pre-F/Alum +CpG subunit vaccine in Balb/C mice with and without RSV prexposure.
  Journal of medical virology · 2026 · Luan N, Zhang H, Lei Z, et al.
  PMID 42132475DOI 10.1002/jmv.70971
• AS01(B)-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702.
  Frontiers in immunology · 2026 · Menezes F, Chen S, Grunenberg N, et al.
  PMID 41909709DOI 10.3389/fimmu.2026.1768201
• Geochemical modeling of rare earth element adsorption onto aluminum hydroxide and hydroxysulfate under variable sulfate conditions.
  Chemosphere · 2026 · Boothe-Lordon TJ, Cravotta CA 3rd, Tasker TL, et al.
  PMID 41863860DOI 10.1016/j.chemosphere.2026.144900
• Protocol for modeling innate immune training by repeated alum exposure in mice (adjuvant conditioning).
  STAR protocols · 2026 · Boccia T, Veloso da Silva MD, Fattori V, et al.
  PMID 41719134DOI 10.1016/j.xpro.2026.104390
• Effectiveness of Moringa oleifera, chitosan, and alum as adsorbents in lake water treatment.
  Environmental science and pollution research international · 2026 · Ngandjui YAT, Agendia PA, Kuvarega AT, et al.
  PMID 41665769DOI 10.1007/s11356-026-37492-7
• Elemental redistribution in tropical soils: insights into REE, U, and Th mobility after extended phosphogypsum use.
  Environmental geochemistry and health · 2026 · Tanure LPP, Vasques ICF, Veloso RW, et al.
  PMID 41652237DOI 10.1007/s10653-026-02991-6
• Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine.
  Frontiers in immunology · 2025 · Stokdyk K, Sahoo A, Gangadhara S, et al.
  PMID 41646968DOI 10.3389/fimmu.2025.1706958

The 10 most recently updated of 190 ClinicalTrials.gov registrations naming Aluminum Sulfate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
  Completed · Phase 1 · Phase 2 · Interventional · 132 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT03284710updated 2026-05-04
• Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
  Recruiting · Phase 1 · Interventional · 300 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT03878121updated 2026-04-21
• Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV
  Active not recruiting · Phase 1 · Interventional · 36 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT05903339updated 2026-04-20
• A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
  Active not recruiting · Phase 3 · Interventional · 321 enrolled · Diamyd Medical AB
  NCT05018585updated 2026-04-15
• Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.
  Completed · Phase 1 · Interventional · 51 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT04915768updated 2026-04-14
• Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV
  Active not recruiting · Phase 1 · Interventional · 52 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT05471076updated 2026-04-13
• Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.
  Not yet recruiting · Interventional · 74 enrolled · Sohag University
  NCT07451561updated 2026-03-05
• Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy
  Suspended · Phase 1 · Interventional · 30 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT06680479updated 2026-03-03
• Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda
  Completed · Phase 2 · Interventional · 1,919 enrolled · Victoria Biomedical Research Institute
  NCT07408297updated 2026-02-13
• Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
  Completed · Phase 1 · Interventional · 32 enrolled · Madhu Chhanda Choudhary
  NCT04985760updated 2026-01-22

Frequently asked questions

What is Aluminum Sulfate used for?

According to FDA labeling, Aluminum Sulfate carries indications including: Uses Temporarily relieves minor skin irritations due to: Poison ivy Poison oak Poison sumac Insect bites Athlete's foot Rashes caused by soaps, detergents, cosmetics, or jewelry. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.

What are the brand names for Aluminum Sulfate?

Aluminum Sulfate is marketed under brand names including Domeboro.